Search

Your search keyword '"Ronzoni M"' showing total 18 results

Search Constraints

Start Over You searched for: Author "Ronzoni M" Remove constraint Author: "Ronzoni M" Database OAIster Remove constraint Database: OAIster
18 results on '"Ronzoni M"'

Search Results

1. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

2. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

3. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

4. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial

5. Changes in body composition during neoadjuvant therapy can affect prognosis in rectal cancer patients: An exploratory study

6. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

7. Signs and symptoms of COVID-19 in patients with multiple sclerosis

8. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

9. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

10. The Italian multiple sclerosis register

11. The Italian multiple sclerosis register

12. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

13. Phase III trial comparing 3-6months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: Safety and compliance in the TOSCA trial

14. Activity and safety of cetuximab plus modified folfoxiri followed by maintenance with cetuximab or bevacizumab for RAS and BRAF wild-type metastatic colorectal cancer a randomized phase 2 clinical trial

15. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

17. Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients

18. Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients

Catalog

Books, media, physical & digital resources